801 studies found for:    "Psoriasis"
Show Display Options
Rank Status Study
1 Recruiting IL-17 Role in Variants of Psoriasis
Conditions: Scalp Psoriasis;   Pustular Palmo-plantar Psoriasis;   Non-pustular Palmo-plantar Psoriasis;   Elbow Psoriasis;   Lower Leg Psoriasis
Intervention:
2 Completed
Has Results
Effects of Etanercept on Nail Psoriasis and Plaque Psoriasis
Conditions: Nail Psoriasis;   Plaque Psoriasis
Intervention: Drug: etanercept
3 Recruiting A Study to Evaluate the Safety and Efficacy of Adalimumab in Subjects With Chronic Plaque Psoriasis and Nail Psoriasis
Conditions: Nail Psoriasis;   Plaque Psoriasis
Interventions: Biological: Adalimumab (ADA);   Other: Placebo
4 Completed
Has Results
Study Evaluating Etanercept for the Treatment of Moderate to Severe Psoriasis
Conditions: Plaque Psoriasis;   Psoriasis
Intervention: Drug: Etanercept
5 Recruiting Tofacitinib Ointment For Chronic Plaque Psoriasis
Conditions: Psoriasis Vulgaris;   Psoriasis
Interventions: Drug: tofacitinib ointment 20 mg/g;   Drug: tofacitinib ointment 10 mg/g;   Drug: placebo ointment (vehicle)
6 Completed A Study to Determine the Efficacy and Safety of 122-0551 in Subjects With Plaque Psoriasis
Conditions: Psoriasis;   Plaque Psoriasis
Interventions: Drug: 122-0551;   Drug: Vehicle
7 Completed
Has Results
Taclonex Ointment With Hydrogel Patch Occlusion for the Treatment of Psoriasis
Conditions: Plaque Psoriasis;   Psoriasis Vulgaris
Interventions: Drug: Taclonex Ointment and Hydrogel Patch;   Drug: Taclonex Ointment
8 Completed Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
Conditions: Actively Extending Plaque Psoriasis;   Moderate to Severe Plaque Psoriasis
Interventions: Drug: IMO-3100;   Drug: Saline for Injection
9 Active, not recruiting Non-interventional Study of Long-term Treatment of Psoriasis With Calcipotriol Plus Betamethasone in Gel Formulation
Conditions: Psoriasis Vulgaris;   Plaque Psoriasis
Intervention: Drug: Daivobet® Gel
10 Completed A Study to Determine the Efficacy and Safety of Halobetasol Propionate Lotion 0.05% in Subjects With Plaque Psoriasis
Conditions: Psoriasis;   Plaque Psoriasis
Interventions: Drug: Halobetasol Propionate Lotion 0.05%;   Drug: Placebo
11 Unknown  Determination of Lymphocyte JAM-C Expression in Patients With Psoriasis Vulgaris
Conditions: Psoriasis;   Psoriasis Vulgaris
Intervention:
12 Completed A Study to Evaluate and Compare the Effectiveness and Metabolism of MK-0873 for the Treatment of Plaque Psoriasis (MK-0873-022-AM1)
Conditions: Psoriasis;   Plaque Psoriasis
Interventions: Drug: 2% MK-0873 Cream;   Drug: MK-0873 vehicle (placebo);   Drug: Calcitriol
13 Completed Apremilast Safety and PK Study in Recalcitrant Plaque Psoriasis
Condition: Psoriasis-Type Psoriasis
Intervention: Drug: Apremilast; CC-10004
14 Active, not recruiting Multiple-dose Regimen Study to Assess Effect of 12 Months of Secukinumab Treatment on Skin Response and Biomarkers in Psoriasis Patients
Condition: Psoriasis, Plaque-type Psoriasis
Interventions: Drug: secukinumab;   Drug: placebo
15 Completed Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
Conditions: Psoriasis;   Plaque-type Psoriasis
Interventions: Drug: Apremilast 10mg;   Drug: Apremilast 20mg;   Drug: Apremilast 30 mg;   Drug: Placebo
16 Recruiting Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) In Japanese Subjects With Moderate-To-Severe Plaque-Type Psoriasis
Conditions: Psoriasis;;   Psoriatic Arthritis;;   Psoriasis Arthropatica
Interventions: Drug: Apremilast;   Drug: Placebo
17 Completed Chronic Plaque Psoriasis Study With Topical Formulation Of GW786034
Conditions: Psoriasis;   Plaque Psoriasis
Intervention: Drug: pazopanib (GW786034)
18 Not yet recruiting A Study to Evaluate the Effectiveness of STELARA ™ (USTEKINUMAB) in the Treatment of Scalp Psoriasis
Conditions: Scalp Psoriasis;   Plaque Psoriasis
Interventions: Drug: Ustekinumab;   Drug: Placebo
19 Completed LEO 90100 Compared to Vehicle in Subjects With Psoriasis Vulgaris
Conditions: Psoriasis Vulgaris;   Plaque Psoriasis
Interventions: Drug: LEO 90100;   Drug: Vehicle
20 Active, not recruiting Paired Psoriasis Lesion, Comparative, Study to Evaluate MOL4239 in Psoriasis
Condition: Psoriasis
Interventions: Drug: MOL4239;   Drug: Placebo

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years